Cargando…
Reasons for enhanced activity of doxorubicin on co-delivery with octa(3-aminopropyl)silsesquioxane
This paper presents results of spectroscopic (NMR, FTIR, fluorescence), Q-TOF mass spectrometry and Z-potential analyses of interactions between octa(3-aminopropyl)silsesquioxane hydrochloride (POSS-NH(2)·HCl) and anticancer drug – doxorubicin hydrochloride. These studies aimed at explanation of the...
Autores principales: | Piorecka, Kinga, Kurjata, Jan, Bak-Sypien, Irena, Cypryk, Marek, Steinke, Urszula, Stanczyk, Wlodzimierz A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9052520/ https://www.ncbi.nlm.nih.gov/pubmed/35495453 http://dx.doi.org/10.1039/d0ra01319f |
Ejemplares similares
-
Novel Polyhedral Silsesquioxanes [POSS(OH)(32)] as Anthracycline Nanocarriers—Potential Anticancer Prodrugs
por: Piorecka, Kinga, et al.
Publicado: (2020) -
Unusual Enhancement of Doxorubicin Activity on Co-Delivery with Polyhedral Oligomeric Silsesquioxane (POSS)
por: Sobierajska, Ewelina, et al.
Publicado: (2017) -
Hydrophilic Polyhedral Oligomeric Silsesquioxane, POSS(OH)(32), as a Complexing Nanocarrier for Doxorubicin and Daunorubicin
por: Piorecka, Kinga, et al.
Publicado: (2020) -
Nanoarchitectonics: Complexes and Conjugates of Platinum Drugs with Silicon Containing Nanocarriers. An Overview
por: Piorecka, Kinga, et al.
Publicado: (2021) -
Acriflavine,
an Acridine Derivative for Biomedical
Application: Current State of the Art
por: Piorecka, Kinga, et al.
Publicado: (2022)